Keyword "PHARMACOLOGICAL CORRECTION" found in the following publications:

• PHARMACOLOGICAL CORRECTION OF INTERCEPT HEMODYNAMICS IN ACUTE KIDNEY DAMAGE (PART 1)

  Introduction: Development of vasoconstriction of kidney arterioles and reduction of renal blood flow is one of the main mechanism ...

  Abstract | Full text (PDF)

• EXPERIMENTAL ASSESSMENT OF IMMUNOREACTIVITY INDICES AND EFFECTIVENESS OF PHARMACOTHERAPY SCHEMES IN SURGICAL MODELS OF ACUTE PANCREATITIS OF VARIOUS SEVERITY
   

  Introduction: The investigation was aimed at assessment of immunoreactivity in the experimental groups of animals and evaluation of ...

  Abstract | Full text (PDF)

• NUCLEAR FACTOR KAPPA B AS A POTENTIAL TARGET FOR PHARMACOLOGICAL CORRECTION ENDOTHELIUM-ASSOCIATED PATHOLOGY

  The nuclear factor kappa B (NF-κB) is one of transcription factors. A high interest in studying the biological role ...

  Abstract | Full text (PDF)

• PHARMACOLOGICAL CORRECTION OF METABOLIC DISTURBANCES IN EXPERIMENTAL ACUTE PANCREATITIS ON THE BACKGROUND OF CHRONIC ALCOHOL INTOXICATION

  Background: Acute pancreatitis ranks third among all acute surgical diseases of the abdominal cavity and is one of the ...

  Abstract | Full text (PDF)

• THE MAIN DIRECTIONS FOR PHARMACOLOGICAL CORRECTION (COMBINATIONS OF DRUGS FOR GENERAL ANESTHESIA) OF NEUROLOGICAL AND COGNITIVE DISORDERS IN PATIENTS WITH NEOPLASMS OF THE CENTRAL NERVOUS SYSTEM

  Introduction: the problem of neuroprotective or neurodegenerative effects of drugs for general anesthesia is relevant in connection with a ...

  Abstract | Full text (PDF)

• SEARCH FOR NEW PHARMACOLOGICAL TARGETS FOR INCREASING THE EFFICIENCY OF CORRECTION OF CARDIOVASCULAR DISEASES

  Introduction: Cardiovascular disease (CVD) is the leading cause of death worldwide: no other reason causes as many deaths a year ...

  Abstract | Full text (PDF)

• PRINCIPLES OF PHARMACOLOGICAL CORRECTION OF PULMONARY ARTERIAL HYPERTENSION

  Definition and classification: Pulmonary hypertension (PH) is a group of life-threatening progressive diseases of various genesis, characterized by a ...

  Abstract | Full text (PDF)

• PHARMACOLOGICAL CORRECTION OF METABOLIC DISORDERS IN EXPERIMENTAL ACUTE PANCREATITIS ON THE BACKGROUND OF CHRONIC ALCOHOL INTOXICATION

  Introduction. Acute pancreatitis and pre-existing diseases (chronic alcohol intoxication) are challenging issues of modern surgery in terms of frequency of deaths ...

  Abstract | Full text (PDF)

• PATHOLOGICAL CONDITIONS ASSOCIATED WITH TAU PROTEIN: MECHANISMS OF DEVELOPMENT AND POSSIBLE BIOLOGICAL TARGETS FOR PHARMACOLOGICAL CORRECTION OF TAU PROTEINOPATHY (REVIEW)

  Background: The pathological process associated with the pathogenic aggregation of tau is called taupathy. The same term is often ...

  Abstract | Full text (PDF)

• COMPLEX CORRECTION OF PSYCHOEMOTIONAL AND IMMUNOLOGICAL CHANGES IN PATIENTS WITH ACNE

  Introduction: The problem of complex therapy of acne attracts the attention of researchers because it accompanied with significant cosmetic ...

  Abstract | Full text (PDF)

• PHARMACOLOGICAL CORRECTION OF INTRARENAL HEMODYNAMIC DISORDERS IN ACUTE KIDNEY INJURY (PART 2)

  Introduction: Treatment of acute kidney injury (AKI) is a complex current problem. Mortality in this pathology is over 50%. ...

  Abstract | Full text (PDF)

• TEST SYSTEM FOR EVALUATION OF THE INFLUENCE OF THE BIOLOGICAL ACTIVITY OF SUBSTANCES ON THE SIGNAL SYSTEM OF NF-ΚB: FOCUS ON THE DERIVATIVES OF 3-HYDROXYPYRIDINE

  Introduction: The nuclear factor kappa B is one of the most promising targets for the development of innovative medicines ...

  Abstract | Full text (PDF)